低血清孕酮影响激素替代治疗周期中冷冻复苏囊胚移植的活产率
该观察性队列研究纳入915例在激素替代治疗(HRT)周期中接受单枚自体冷冻复苏囊胚移植的患者,于移植日早晨检测血清孕酮浓度。血清孕酮≤9.8 ng/ml组活产率显著低于>9.8 ng/ml组(26.1% vs 33.2%,P=0.045),早期流产率显著更高(35.9% vs 21.6%,P=0.005);多因素分析调整混杂后低孕酮仍与较低活产率相关(OR 0.68,95%CI 0.48-0.97)。
要点
- 移植日血清孕酮≤9.8 ng/ml组活产率26.1%,低于>9.8 ng/ml组的33.2%(P=0.045)。
- 移植日血清孕酮≤9.8 ng/ml组早期流产率35.9%,高于>9.8 ng/ml组的21.6%(P=0.005)。
- 多因素调整后低孕酮(≤9.8 ng/ml)仍与较低活产率相关(OR 0.68,95%CI 0.48-0.97)。
核心结论
- 在HRT周期单枚自体冷冻复苏囊胚移植中,需要最低血清孕酮浓度以优化生殖结局。
- 改变孕酮给药途径或剂量能否提高妊娠率需进一步研究,以实现HRT周期患者的个体化治疗。
研究设计与样本
- 观察性队列研究,纳入915例在HRT周期中接受单枚自体冷冻复苏囊胚移植的患者,使用阴道微粒化孕酮。
- 纳入时间为2019年1月至2020年3月,每例患者仅纳入一次。
- 于胚胎移植日早晨由单一实验室检测血清孕酮浓度,主要终点为活产率(LBR)。
- 采用单因素和多因素逻辑回归模型进行统计分析。
主要发现
- 移植日血清孕酮浓度中位数(第25-75百分位)为12.5 ng/ml(9.8-15.3)。
- 总体活产率为31.5%(288/915)。
- 着床率无显著差异(40.7% vs 44.9%)。
- 血清孕酮≤第25百分位(≤9.8 ng/ml)组活产率显著低于>第25百分位组(26.1% vs 33.2%,P=0.045)。
- 血清孕酮≤9.8 ng/ml组早期流产率显著高于>9.8 ng/ml组(35.9% vs 21.6%,P=0.005)。
关键数值与推荐
- 血清孕酮低值定义为≤第25百分位,即≤9.8 ng/ml。
- 低孕酮(≤9.8 ng/ml)与较低活产率相关(OR 0.68,95%CI 0.48-0.97)。
- 活产率比较:≤9.8 ng/ml组26.1% vs >9.8 ng/ml组33.2%(P=0.045)。
- 早期流产率比较:≤9.8 ng/ml组35.9% vs >9.8 ng/ml组21.6%(P=0.005)。
临床怎么用
- 在HRT周期单枚自体冷冻复苏囊胚移植中,移植日血清孕酮≤9.8 ng/ml与较低活产率和较高早期流产率相关。
- 改变孕酮给药途径或剂量能否改善妊娠率需进一步研究,以个体化治疗HRT周期患者。
局限性
- 改变孕酮给药途径或剂量能否提高妊娠率需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does serum progesterone concentration on the day of vitrified-warmed embryo transfer affect live birth rate (LBR) with hormonal replacement therapy (HRT) cycles? DESIGN: Observational cohort study of patients (n = 915) undergoing single autologous vitrified-warmed blastocyst transfer under HRT using vaginal micronized progesterone. Women were included once, between January 2019 and March 2020. Serum progesterone concentration was measured by a single laboratory on the morning of embryo transfer. The primary end point was LBR. Univariate and multivariate logistic regression models were used for statistical analyses. RESULTS: Median (25th-75th percentile) serum progesterone concentration on the day of embryo transfer was 12.5 ng/ml (9.8-15.3). The LBR was 31.5% (288/915) in the overall population. No significant differences were found in implantation rates (40.7% versus 44.9%); LBR was significantly lower in women with a progesterone concentration ≤25th percentile (≤9.8 ng/ml) (26.1% versus 33.2%, P = 0.045) versus women with a progesterone concentration >25th percentile. This correlated with a significantly higher early miscarriage rate (35.9% versus 21.6%, P = 0.005). After adjusting for potential confounding factors in multivariate analysis, low serum progesterone levels (≤9.8 ng/ml) remained significantly associated with lower LBR (OR 0.68 95% CI 0.48 to 0.97). CONCLUSION: A minimum serum progesterone concentration is needed to optimize reproductive outcomes in HRT cycles with single autologous vitrified-warmed blastocyst transfer. Whether modifications of progesterone administration routes, dosage, or both, can improve pregnancy rates needs further study so that treatment of patients undergoing HRT cycles can be further individualized.
引用
- Maignien C, Bourdon M, Marcellin L, et al. Low serum progesterone affects live birth rate in cryopreserved blastocyst transfer cycles using hormone replacement therapy. Reprod Biomed Online. 2021. PMID: 34980570. doi:10.1016/j.rbmo.2021.11.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。